Effects of simvastatin and atorvastatin on biochemical and hematological markers in patients with risk of cardiovascular diseases.

about

Pre-treatment with simvastatin prevents the induction of diet-induced atherosclerosis in a rabbit model.

P2860

Q37581629-10EC5668-FAEF-4C36-9DEA-1E3F6F78EB31

P2860

Effects of simvastatin and atorvastatin on biochemical and hematological markers in patients with risk of cardiovascular diseases.

Item

http://www.wikidata.org/entity/Q36183390

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Effects of simvastatin and ato ...... sk of cardiovascular diseases.

@ast

Effects of simvastatin and ato ...... sk of cardiovascular diseases.

@en

type

Item

label

Effects of simvastatin and ato ...... sk of cardiovascular diseases.

@ast

Effects of simvastatin and ato ...... sk of cardiovascular diseases.

@en

prefLabel

Effects of simvastatin and ato ...... sk of cardiovascular diseases.

@ast

Effects of simvastatin and ato ...... sk of cardiovascular diseases.

@en

P1476

Effects of simvastatin and ato ...... sk of cardiovascular diseases.

@en

P2093

Jia-Fu Feng

http://www.w3.org/2001/XMLSchema#string

Jian-Bo Xian-Yu

http://www.w3.org/2001/XMLSchema#string

Yu-Chun Chen

http://www.w3.org/2001/XMLSchema#string

Yu-Wei Yang

http://www.w3.org/2001/XMLSchema#string

P2860

The preventive effect of atorvastatin on atrial fibrillation: a meta-analysis of randomized controlled trials

Non-cardiovascular effects associated with statins

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Effect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials.

Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcome.

Assessing the adherence to and the therapeutic effectiveness of hypolipidemic agents in a population of patients in Brazil: a retrospective cohort study.

Evaluation of sexual dimorphism in the efficacy and safety of simvastatin/atorvastatin therapy in a southern Brazilian cohort.

Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.

No changes of cholesterol levels with a commercially available glucosamine product in patients treated with lipid lowering drugs: a controlled, randomised, open cross-over trial.

Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.

P304

13983-13989

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26550356

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

4613041

http://www.w3.org/2001/XMLSchema#string

Effects of simvastatin and atorvastatin on biochemical and hematological markers in patients with risk of cardiovascular diseases.

about

P2860

P2860

Effects of simvastatin and atorvastatin on biochemical and hematological markers in patients with risk of cardiovascular diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932